A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer

• Status: Recruiting
• Trial end date: 2023-10-01
• Target enrollment: 0
• Participant gender: All

Summary

In this research, the patients with advanced lung cancer accompanied by pain and discomfort were treated by injecting freshly manufactured tissue permeable hyaluronan fragment HA35 into the tissue under abdominal adipose.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nakhia Impex LLC
• Collaborator: Mongolian National University of Medical Sciences
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

• Age>=18 years old

• Sign the informed consent form voluntarily.

• Expected survival ≥3 months.

• Pathologically confirmed locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), which is currently not suitable for local treatment such as radical surgery or radiotherapy.

• The subject has good compliance and cooperates with the follow-up.

Exclusion Criteria:

• Subjects who are receiving systematic steroid treatments before the first cell treatment.

• Subjects with a history of mental disorders or drug abuse that may influence treatment compliance.

• Women in pregnancy or lactation or are expected to be pregnant during the study.